← Back to headlines
CytomX outlines registrational trial plans for Varseta-M in third-line colorectal cancer with initial study start in 2027
16 Mar, 16:05 — 16 Mar, 16:05
Sources
Showing 1 of 1 sources
Related Stories
First case of severe mpox disease reported in major city: ‘Life-threatening’
11m ago
Vaccine critics keep the pressure on, even as RFK Jr. shifts focus
11m ago
Food ingredients that are banned in the EU but not the US
13m ago
Weight loss miracle drugs can cause vision loss, one more than the other
20m ago